同时的胃肠道出血预防与双重抗血小板治疗使用
Dan Lei Zhou1, Muhammad Moiz Tahir2, Rohma Saleemi3
1Paul L. Foster School of Medicine, Texas Tech Health Sciences Center, El Paso, TX 79905, USA.
Gastroenterology research
|July 21, 2025
概括
质子抑制剂 (PPI) 和组胺-2-受体对抗剂 (H2RAs) 在双抗血小板治疗 (DAPT) 患者的胃肠道出血 (GIB) 预防方面进行了比较. 由于数据冲突和药物相互作用,需要个性化策略.
科学领域:
- 胃肠病学和药理学 胃肠病学和药理学
- 临床治疗学 临床治疗学
- 基于证据的医学基于证据的医学.
背景情况:
- 胃肠道出血 (GIB) 是双抗血小板治疗 (DAPT) 患者的重大风险.
- 质子抑制剂 (PPI) 是GIB预防的标准药物,但可能与克洛皮多格雷尔相互作用.
- 作为替代药物,基因组-2-受体对抗剂 (H2RAs) 正在被探索,特别是在并发症中.
研究的目的:
- 审查和比较PPI与H2RA对DAPT患者GIB预防的有效性和安全性.
- 探索新兴的替代品,如竞争性酸阻断剂 (PCABs).
- 强调需要个性化的GIB预防策略.
主要方法:
- 对DAPT患者GIB预防的比较研究的综合文献综述.
- 对PPI和H2RA的疗效,安全性概况和药物相互作用数据的分析.
- 包括最近关于PCAB和患者特定因素的发现.
主要成果:
- PPI是有效的,但携带通过CYP2C19.19的克洛皮多格雷尔相互作用的风险.
- 在特定的患者亚组中,H2RAs显示出潜在的益处,包括患有心血管或脏问题的患者.
- PCABs代表了一种有前途的新类GIB预防.
结论:
- 在DAPT患者中最佳的GIB预防需要个性化治疗计划.
- 平衡疗效,安全性和药物相互作用对于患者管理至关重要.
- 需要进一步的大规模研究来完善临床指导方针并解决数据缺口.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
648
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
648
01:26Peptic Ulcer Disease IV: Management
146
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
146
01:28Esophageal Varices-II: Clinical Features and Management
145
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
145
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
600
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
600
01:27Coronary Artery Disease V: Interprofessional Care
34
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
34
01:30Venous Thrombosis IV: Nursing Management
24
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
24